Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN
Global Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Highlights - 2022
Idiopathic pulmonary fibrosis - Wikipedia
Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions: Molecular Therapy - Methods & Clinical Development
Targeting fibrosis: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
Qureight announces world's first digital biomarker for lung fibrosis will 'transform' clinical trials - PMLiVE
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial - The Lancet Respiratory Medicine
The therapy of idiopathic pulmonary fibrosis: what is next? | European Respiratory Society
Clinical Trials | Pulmonary Fibrosis Foundation
Live Well Breathe Better- Pulmonary Fibrosis - Understanding Pulmonary Fibrosis Clinical Trials - YouTube
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Clinical Trials | Pulmonary Fibrosis Foundation
Idiopathic Pulmonary Fibrosis (IPF) - Renstar Medical Research
.png "REMAP-ILD: The future of clinical trials in pulmonary fibrosis – Action for Pulmonary Fibrosis")
REMAP-ILD: The future of clinical trials in pulmonary fibrosis – Action for Pulmonary Fibrosis
Clinical Trials | Pulmonary Fibrosis Foundation
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis - The Lancet Respiratory Medicine
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development | SpringerLink
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Clinical trials in lung fibrosis - Lung Foundation Australia
Idiopathic pulmonary fibrosis: current challenges and future perspectives | European Respiratory Society
Clinical Trials for Pulmonary Fibrosis: How Can Participation Be Improved? - Xtalks
Phase IV IPF Clinical Trials | ILD Collaborative
Recent Clinical Trials on Idiopathic Pulmonary Fibrosis | Download Table
